-transparent.png){kind=logo}
Syncytium inhibition assay to distinguish between HTLV-I and HTLV-II infection was performed with sera and cerebrospinal fluid of 15 HTLV-I-associated myelopathy (HAM) patients. Also, genome analysis of HTLV-II proviral DNA was performed in some HAM patients by use of the polymerase chain reaction method. All of the HAM patients were negative for co-infection with HTLV-II.
Related Publications
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
July 1991,
Lancet (London, England),
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
October 1991,
Lancet (London, England),
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
June 1992,
Uirusu,
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
September 1998,
Arquivos de neuro-psiquiatria,
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
January 1999,
Ryoikibetsu shokogun shirizu,
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
March 1992,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
January 1998,
Ryoikibetsu shokogun shirizu,
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
August 1990,
The New England journal of medicine,
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
June 1992,
Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
K Miyamoto, and
T Nakamura, and
S Nagataki, and
N Tomita, and
K Kitajima
August 1987,
Gan to kagaku ryoho. Cancer & chemotherapy,
